Headlands Technologies’s Allarity Therapeutics ALLR Stock Holding History

Headlands Technologies’s Portfolio ALLR Stock Details ALLR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1	Closed	-$4	–	1166
2024 Q2	$4	Buy	+1	New	+$39	﹤0.01%	1101

Other funds holding ALLR

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Headlands Technologies's ALLR Position: Q3 2024 in Review

Headlands Technologies sold out of Allarity Therapeutics (ALLR) in Q3 2024, closing a stake of 1 share — an estimated $4 sold.

Headlands Technologies first reported a position in ALLR in Q2 2024 and held it in 1 quarter. The position peaked at $4 in Q2 2024. 4 funds tracked by Wall St. Rank hold ALLR as of Q3 2024.

Headlands Technologies reported no remaining Allarity Therapeutics position as of Q3 2024 after selling out during the quarter.
Headlands Technologies sold 1 Allarity Therapeutics share in Q3 2024, an estimated $4.
Headlands Technologies first reported a position in Allarity Therapeutics in Q2 2024 and held it in 1 quarter.
Headlands Technologies's Allarity Therapeutics position peaked at $4 in Q2 2024.
4 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q3 2024.

Based on Headlands Technologies's 13F filing for Q3 2024, filed 12 Nov 2024.